Silymarin in the Prevention and Treatment of Liver Diseases and Primary Liver Cancer

医学 脂肪性肝炎 氧化应激 药理学 脂肪肝 肝硬化 肝细胞癌 血管生成 肝再生 肝细胞 癌症研究 肝癌 癌症 肝损伤 内科学 再生(生物学) 化学 生物 体外 生物化学 疾病 细胞生物学
作者
János Fehér,Gabriella Lengyel
出处
期刊:Current Pharmaceutical Biotechnology [Bentham Science]
卷期号:13 (1): 210-217 被引量:213
标识
DOI:10.2174/138920112798868818
摘要

In chronic liver diseases caused by oxidative stress (alcoholic and non-alcoholic fatty liver diseases, drug- and chemical-induced hepatic toxicity), the antioxidant medicines such as silymarin can have beneficial effect. Liver cirrhosis, non-alcoholic fatty liver and steatohepatitis are risk factors for hepatocellular carcinoma (HCC). Insulin resistance and oxidative stress are the major pathogenetic mechanisms leading the hepatic cell injury in these patients. The silymarin exerts membrane-stabilizing and antioxidant activity, it promotes hepatocyte regeneration; furthermore it reduces the inflammatory reaction, and inhibits the fibrogenesis in the liver. These results have been established by experimental and clinical trials. According to open studies the long-term administration of silymarin significantly increased survival time of patients with alcohol induced liver cirrhosis. Based on the results of studies using methods of molecular biology, silymarin can significantly reduce tumor cell proliferation, angiogenesis as well as insulin resistance. Furthermore, it exerts an anti-atherosclerotic effect, and suppresses tumor necrosis factor-alpha-induced protein production and mRNA expression due to adhesion molecules. The chemopreventive effect of silymarin on HCC has been established in several studies using in vitro and in vivo methods; it can exert a beneficial effect on the balance of cell survival and apoptosis by interfering cytokines. In addition to this, anti-inflammatory activity and inhibitory effect of silymarin on the development of metastases have also been detected. In some neoplastic diseases silymarin can be administered as adjuvant therapy as well. Keywords: Cancer prevention, chronic liver diseases, hepatitis B virus, hepatitis C virus, hepatocellular carcinoma, silymarin, steatohepatitis, oxidative stress, Liver cirrhosis, membrane-stabilizing, insulin resistance, metastases, adjuvant therapy, hepatobiliary diseases
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
王小少完成签到,获得积分10
1秒前
胜天半子发布了新的文献求助10
1秒前
林林发布了新的文献求助10
1秒前
an发布了新的文献求助10
1秒前
1秒前
2秒前
大模型应助想人陪的万言采纳,获得10
2秒前
3秒前
3秒前
3秒前
熊猫发布了新的文献求助10
3秒前
哈基米德应助科研通管家采纳,获得20
4秒前
sunran完成签到 ,获得积分10
4秒前
4秒前
FashionBoy应助科研通管家采纳,获得10
4秒前
wlscj应助科研通管家采纳,获得20
4秒前
SciGPT应助科研通管家采纳,获得10
4秒前
4秒前
narcol完成签到,获得积分10
4秒前
领导范儿应助科研通管家采纳,获得10
4秒前
excellent发布了新的文献求助20
4秒前
ding应助科研通管家采纳,获得10
4秒前
NexusExplorer应助科研通管家采纳,获得10
4秒前
pluto应助科研通管家采纳,获得10
4秒前
4秒前
lalala应助科研通管家采纳,获得10
5秒前
wlscj应助科研通管家采纳,获得20
5秒前
5秒前
科研通AI2S应助科研通管家采纳,获得10
5秒前
ding应助科研通管家采纳,获得10
5秒前
meng完成签到,获得积分10
5秒前
浮游应助科研通管家采纳,获得10
5秒前
5秒前
5秒前
5秒前
5秒前
6秒前
Yxy2021完成签到 ,获得积分10
6秒前
菜菜完成签到,获得积分20
6秒前
woosa完成签到 ,获得积分10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
量子光学理论与实验技术 1000
The Social Work Ethics Casebook: Cases and Commentary (revised 2nd ed.). Frederic G. Reamer 800
Beyond the sentence : discourse and sentential form / edited by Jessica R. Wirth 600
Holistic Discourse Analysis 600
Vertébrés continentaux du Crétacé supérieur de Provence (Sud-Est de la France) 600
Vertebrate Palaeontology, 5th Edition 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5329313
求助须知:如何正确求助?哪些是违规求助? 4468897
关于积分的说明 13907268
捐赠科研通 4361932
什么是DOI,文献DOI怎么找? 2396101
邀请新用户注册赠送积分活动 1389467
关于科研通互助平台的介绍 1360296